+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 0 - 90Years
All Genders
ID06726642

Evaluating Cell-free DNA Blood Testing for Early Cancer Detection in Hereditary and High-risk Cancer Syndromes

Led by University Health Network, Toronto · Updated on 2026-10-08

1000

Participants Needed

8

Research Sites

104 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating an experimental blood test called cell-free DNA cfDNA analysis to detect early tumors in patients with hereditary cancer syndromes. This study aims to compare the cancer detection rates between patients receiving this new blood test and those receiving standard cancer care. It also seeks to determine if the test leads to earlier cancer diagnosis and how it impacts patient outcomes, including quality of life and psychological distress. Participants are divided into two groups. Those in the experimental group provide blood samples every four months for four years, which are analyzed for cfDNA to detect cancer-related genetic changes. Results are shared with participants, and if positive, follow-up diagnostic tests are offered. The control group continues standard cancer surveillance without the cfDNA test. Both groups complete questionnaires and interviews about their experiences and perceptions of the testing. Throughout the study, participants undergo regular blood sample collections alongside routine clinical care when possible to minimize extra procedures. Researchers assess cancer detection rates, the timing of cancer diagnosis, and psychological effects such as cancer worry and anxiety over four years. The study also monitors how access to cfDNA results influences patients perceptions and quality of life. This study is expected to last until 2031, with primary outcomes assessed over four years from enrollment.

CONDITIONS

Brief Title

CfDNA in Hereditary And High-risk Malignancies 2

Research Team

J

Julia Sobotka, MSc

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here